Nova Eye Medical (EYE) Discussion, page-2460

Exactly, seems to be really only a matter of time here. We can clearly see the very high growth rate in the US is being sustained with very little effort (they only have 6 sales reps each generating huge amounts of revenue), and all indicators point to that growth rate only continuing to increase as they significantly expand the sales force. There's no reason to doubt either that they won't be able to replicate this performance outside the US once they decide to really focus on the rest of the world. The cash flow positive news could certainly come some time this year as well. Fundamentally iTrack Advance is performing incredibly well and growing exponentially, and so every extra day the price remains at these subdued levels the differential between the fair value and market value grows significantly wider.

And of course the 2RT deal could come at any moment really which would certainly be a game changer for the company...